Synthesis, anticancer, anti-HIV-1, and antimicrobial activity of some tricyclic triazino and triazolo[4,3-e]purine derivatives
作者:Fawzia A. Ashour、Samia M. Rida、Soad A. M. El-Hawash、Mona M. ElSemary、Mona H. Badr
DOI:10.1007/s00044-011-9612-6
日期:2012.7
antineoplastic, anti-HIV-1 and antimicrobial activities, the synthesis of some new triazino and triazolo[4,3-e]purine derivatives is described: 6,8-dimethyl-1,4-dihydro-1,2,4-triazino[4,3-e]purine-7,9(6H, 8H)-diones 3–6; 5,7,9-trimethyl-1,2,4-triazolo[4,3-e]purine-6,8(5H, 7H, 9H)-diones 11–13, together with the synthesis of the 8-substituted purine derivative: 8-(3,5-diamino-1H-pyrazol-4-yl)diazenyl-1,3-dimethyl-1H-purine-2
为了努力建立具有改进的抗肿瘤药,抗HIV-1和抗菌活性的新候选药物,描述了一些新的三嗪并三唑[4,3-e]嘌呤衍生物的合成:6,8-二甲基-1,4-二氢-1,2,4-三嗪[4,3-E]嘌呤-7,9(6H,8H) -二酮3 - 6 ; 5,7,9三甲基-1,2,4-三唑并〔4,3-E]嘌呤-6,8-(5H,7H,9H) -二酮11 - 13,与8取代的嘌呤的合成在一起衍生物:8-(3,5-二氨基-1H-吡唑-4-基)二氮烯-1,3-二甲基-1H-嘌呤-2,6(3H,7H)-二酮7。测试了制备的化合物的体外抗癌,抗HIV和抗菌活性。体外抗癌筛选结果显示化合物3对黑色素瘤MALME-3 M,非小细胞肺癌HOP-92和乳腺癌T-47D表现出相当大的活性(GI 50值分别为25.2、31.8和32.9μM )。抗HIV-1的结果表明化合物7和13c表现出中等活性(在2×10 -4 M时最大的细胞保护百分比分别为30